Neuraxis, Inc. (NRXS) is a publicly traded Healthcare sector company. As of July 24, 2026, NRXS trades at $7.06 with a market cap of $85.08M and a P/E ratio of -8.66. NRXS moved +2.04% today. Year to date, NRXS is +54.41%; over the trailing twelve months it is +153.99%. Its 52-week range spans $1.33 to $9.33. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces NRXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover NRXS: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $7.06 |
| Market Cap | $85.08M |
| P/E Ratio | -8.66 |
| EPS | $-0.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.33 |
| 52-Week Low | $1.33 |
| Volume | 40.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.28M |
| Net Income | $-7.28M |
| Gross Margin | 85.00% |
1 analysts cover NRXS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.